Profil
Christopher C.
Feistel was associated with the company nRichDX, Inc. where he held the position of Chief Technology Officer from 2005 to 2017.
He is also the founder of nRichDX, Inc. which was founded in 2005.
Anciens postes connus de Christopher C. Feistel
| Sociétés | Poste | Fin |
|---|---|---|
nRichDX, Inc.
 nRichDX, Inc. Medical DistributorsDistribution Services nRichDX, Inc. develops vitro diagnostic products and solutions. It provides the sensitive targeted cell enrichment solution for the cancer patients. The firm’s products are EpiSeP, paramagnetic anti bodies, conjugate antibodies and stains, laboratory reagents, specimen debulking and mixing tools. The company was founded by Chris Feistel and Robert L. Coleman on January 20, 2005 and is headquartered in Irvine, CA. | Fondateur | 01/07/2017 |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
nRichDX, Inc.
nRichDX, Inc. Medical DistributorsDistribution Services nRichDX, Inc. develops vitro diagnostic products and solutions. It provides the sensitive targeted cell enrichment solution for the cancer patients. The firm’s products are EpiSeP, paramagnetic anti bodies, conjugate antibodies and stains, laboratory reagents, specimen debulking and mixing tools. The company was founded by Chris Feistel and Robert L. Coleman on January 20, 2005 and is headquartered in Irvine, CA. | Distribution Services |
